BioKier
OverviewSuggest Edit
BioKier is a clinical-stage medical food and pharmaceutical company developing oral products for people who are not able to manage their glucose. It offers mimicking product that improve or resolve diabetes in people undergoing the surgery for obesity. The product also helps in managing hypertriglyceridemia, metabolic syndrome, and obesity.
| Type | Private | |
| Founded | 2008 | |
| Website | biokier.com |
Latest Updates
| Employees (est.) (May 2020) | 4 | |
| Cybersecurity rating | B | More |
Key People/Management at BioKier
Roger D. Nolan
Co-Founder, President and COO
W. Bennett Love
VP and Chief Financial Officer (Part-Time)
Jerzy Szewczyk
Co-Founder, CEO and CSO
BioKier Financials and Metrics
Summary Metrics
Founding Date | 2008 |
BioKier latest funding size | $150 k |
BioKier Cybersecurity Score
BioKier Online and Social Media Presence
BioKier's Trends
BioKier Blogs
January 26, 2021
Completion of 4-week BKR-017 study in type 2 diabetes subjects and upcoming plans
Despite significant delays related to COVID-19, in late 2020 BioKier completed a 4-week study of BKR-017 in type 2 diabetes subjects. Dr. Kishore Gadde’s team at Pennington Biomedical Research Center (PBRC) successfully recruited and enrolled 14 subjects in the study. All of those subjects completed…
BioKier Frequently Asked Questions
When was BioKier founded?
BioKier was founded in 2008.
Who are BioKier key executives?
BioKier's key executives are Roger D. Nolan, W. Bennett Love and Jerzy Szewczyk.
How many employees does BioKier have?
BioKier has 4 employees.
Who are BioKier competitors?
Competitors of BioKier include Ember Therapeutics, Novaremed and Gan & Lee Pharmaceuticals.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies